Customized transcription factors that control gene expression in response to small molecules can act as endogenous molecular biosensors and are valuable tools for synthetic biology. We previously engineered the Escherichia coli regulatory protein AraC to respond to non-native inducers such as D-arabinose and triacetic acid lactone. Those prior studies involved the construction and screening of individual 4-or 5-site saturation mutagenesis libraries, followed by iterative rounds of positive-and negative fluorescence-activated cell sorting (FACS). Here we describe an improved screening platform and the isolation of several new and potentially useful AraC variants that respond to vanillin and salicylic acid. To increase throughput and reduce total screening time, selection steps were added to the sorting workflow. Two different site-saturation libraries and a random mutagenesis library were pooled together and >10 8 variants were subjected to iterative FACS and selection in search of variants responding to a panel of compounds. The new phenolicsensing variants show responses >100-fold over background and are highly specific towards their target compound. The isolation of these variants further demonstrates the potential for engineering the AraC transcriptional regulatory protein for molecular sensing and reporting, and our improved screening system should prove effective in designing similar biosensors.
Background
Metabolite-responsive transcriptional regulatory proteins (TRPs) are valuable tools in metabolic engineering, both as dynamic regulators of metabolic pathway gene expression, and as genetically encoded molecular reporters that enable the directed evolution of better producing strains via high-throughput screens or selections (Dietrich et al., 2010; Qian and Cirino, 2016; Rogers et al., 2016; Wang and Cirino, 2016) . When a TRP that responds to a target metabolite is desired but yet to have been discovered, options include using gene mining approaches (Huang et al., 2011) or transcriptomic analyses (Wang and Zhang, 2014) to identify putative TRPs. Alternately, one may alter the inducer specificity of a known TRP toward the target metabolite using protein engineering techniques (Dietrich et al., 2013; Feng et al., 2015; Taylor et al., 2015) . We have used this last approach to design new molecular reporters based on the Escherichia coli AraC regulatory protein, which natively activates gene expression at promoter P BAD in response to inducer Larabinose (L-ara) (Tang and Cirino, 2011; Tang et al., 2008 Tang et al., , 2013 . Our approach has been to screen large libraries of AraC variants for responsiveness to different small molecules. AraC is composed of a (C-terminal) DNA-binding domain and a ligand-binding domain that includes an N-terminal arm, known to play a critical role in mediating the AraC dimer's switch between repressing and activating conformations (Saviola et al., 1998; Wu and Schleif, 2001a; Dirla et al., 2009) . We have used saturation mutagenesis to simultaneously randomize two groups of four (Tang et al., 2008) and one group of five (Tang and Cirino, 2011; Tang et al., 2013) residue positions lying in the ligand binding pocket (including residue position eight, found on the N-terminal arm), corresponding to individual libraries of~10 6 and 3 × 10 7 araC mutants. Screening for and isolation of variants responsive to the new inducers Darabinose, mevalonate or triacetic acid lactone (TAL) was accomplished through iterative rounds of fluorescence-activated cell sorting (FACS), in which each round included a 'positive' sort to enrich clones expressing GFP in the presence of exogenously added inducer, and a 'negative' sort to discard constitutive or non-specific clones.
Our initial TAL-responsive AraC variant (AraC-TAL1) was isolated following 10-round of alternating between positive-and negative-FACS sorting. We more recently showed that a variety of similar but different TAL-responsive variants could be isolated, all from the same starting library of five randomized residue positions (P8, T24, H80, Y82, H93), by simply altering the stringency and/or frequency of positive and negative sort steps (Frei et al., 2016) . With the greater goal of expanding the set of small molecules that could be recognized by AraC variants, we have further refined our reporter screening system and explored screening strategies that also incorporate growth selection on ampicillin, where AraC variants regulate expression of bla encoding β-lactamase. We then screened three different AraC libraries for variants responsive to a panel of 10 different small molecules (each containing a six-membered ring). Here we describe our modified library screening method and the resulting isolated AraC variants that respond to vanillin and salicylic acid.
Methods

General
Restriction enzymes, Phusion High-Fidelity DNA polymerase and T4 DNA ligase were purchased from New England Biolabs (Ipswich, MA). Oligonucleotides were synthesized by Integrated DNA Technologies (Coralville, IA). DNA sequencing was performed at SeqWright (Houston, TX) and Genewiz (South Plainfield, NJ). All chemicals were purchased from Sigma-Aldrich (St. Louis, MO). Molecular biology techniques for DNA manipulation were performed according to standard protocols (Sambrook and Russell, 2001) . All cultures were grown using lysogeny broth (LB). Antibiotics and IPTG were prepared as a ×1000 stock solution in purified water and sterile filtered with EMD Millipore Millex-GP syringe driven filters (EMD Millipore, Cat. No. SLGP033RS) .
Target compounds were all dissolved in the respective medium as 10× stocks. Compounds were titrated to pH 7 with NaOH, and sterile filtered with EMD Millipore Millex-GP syringe driven filters. All solutions were stored at 4°C. Phloroglucinol, vanillin and gallic acid were all stored in light resistant tubes and made fresh. The concentrations of compounds in liquid cultures were quantified using high-performance liquid chromatography (HPLC) with an Aminex HPX-87H ion-exclusion column Hercules, CA, and measured by RID (Shimadzu, Cat. No. RID-10A) or UV absorbance (Shimadzu, .
Culturing methods
To obtain growth curves of the AraC-TAL biosensor in the presence of glycerol, pPCC1202 (10 ng) was transformed into HF19 electrocompetent cells harboring pPCC442. The transformation outgrowths were diluted 10-fold in LB supplemented with 50 μg/mL apramycin and 25 μg/mL chloramphenicol (LB + A + C). The culture was grown to an optical density at 595 nm (OD) = 2 and then diluted to an OD = 0.2 in LB supplemented with apramycin, in order to dilute cells not harboring any plasmid. The subcultures were grown to an OD = 6 and diluted a final time to an OD = 0.2 in 125 mL Erlenmeyer flasks biosensor growth media ('BGM'; LB,1% v/v glycerol, 50 mM TES buffer, pH 7.0 with NaOH) supplemented with 50 μg/mL apramycin, 25 μg/mL chloramphenicol, 100 μM IPTG (BGM + A + C + 100I), with or without 5 mM TAL, and the respective concentration of glycerol (0-137 mM glycerol prepared in purified water and filtered with EMD Millipore Millex-GP syringe driven filters). Aliquots (200 μL) were taken out for each time point and washed once with phosphate buffered saline pH 7.4 (PBS). The samples were measured for OD on a BMG Labtech NOVOstar spectrophotometer and the fluorescence (Ex: 400 nm; Em: 510 nm) on a Molecular Devices SpectraMax Gemini EM.
Library screening
Samples were prepared for screening by transforming 10 ng of the plasmid DNA into HF19 electrocompetent cells. The transformation outgrowths were diluted 10-fold in LB containing the appropriate 50 μg/mL apramycin. The culture was then grown to an OD = 2 and diluted to an OD = 0.2 in LB + A in order to dilute out the cells not harboring any plasmid. The subcultures were grown to an OD = 6 and diluted final time to an OD = 0.2 in BGM + A + 100 μM IPTG and the appropriate concentration of the target compound in 125 mL Erlenmeyer flask. Cells were harvested after 6 h of incubation at 37°C, 250 rpm (OD~10) and washed with an equal volume of PBS. The cell OD and bulk fluorescence were measured on a BMG Labtech NOVOstar spectrophotometer and a Molecular Devices GeminiEX fluorescence plate reader, respectively. The washed cells were diluted 1:100 in PBS and analyzed on a FACSJazz (BD Biosciences). The appropriate cultures were then subjected to FACS. Clones were isolated by either collecting the top 1% of the population based on the 488/520 fluorescence histogram (positive sort) or collecting the bottom population relative to the bottom 99% of the GFPuv fluorescence histogram of wild-type AraC not induced (negative sort). After the sort finished, the samples were treated one of two ways: (i) samples from a negative sort were diluted 1:1 with 2xYT medium (e.g. 20 mL of sorted sample mixed with 20 mL of 2xYT), and half concentrations of antibiotics. Cultures were then incubated at 37°C 250 rpm until they reached an OD = 2. They were diluted to OD = 0.2 in LB supplemented with apramycin. From here, samples were treated as described above for the subsequent round of sorting. (ii) Samples from a positive sort were transferred to a centrifuge tube and treated according to Ramesh and coworkers (Ramesh et al., 2015) . Briefly, the cells were pelleted by centrifugation at 17 900 × g for 10 min. The medium was discarded and the plasmid DNA was harvested using a modified protocol from a Zymo Plasmid Miniprep Kit. The cell pellet (even if not visible) was suspended in 200 μL of PBS. The lysis buffers were adjusted accordingly and a column from the Zymo Clean and Concentration Kit was used to purify the plasmid DNA. Each sample was eluted from the column with 10 μL of Zymo elution buffer. The isolated plasmid DNA was then transformed into electroporation competent HF19 cells harboring pPCC422. The outgrowths were diluted and treated as described above for the subsequent round of sorting. After each sort, plasmid DNA was isolated from an aliquot of the subcultures prior to dilution in BGM for future analysis and high-throughput sequencing.
Selections were carried out by transforming 10 ng of the respective population into SQ12 electrocompetent cells. The outgrowths were either diluted as described above for FACS, or directly plated onto LB-agar plates supplemented with 1% glycerol, 50 μg/mL apramycin, 100-300 μg/mL ampicillin and 100 μM IPTG, as well as the respective compound. For the former protocol, cells were plated prior to being diluted in BGM (see above). All selection plates were grown at 37°C until colonies were visible and still spatially separated (approximately 8 hr). Plasmid DNA was isolated from the selection plates by scraping the plates with 2-5 mL of purified water. The cells were pelleted and the plasmid DNA was extracted using a QIAprep Spin Miniprep kit (QIAGEN, Cat. No. 27 106). The plasmid DNA was then transformed into the appropriate strain for the subsequent round of screening.
Deep-well plate endpoint clone screening
Library endpoint plasmid DNA was isolated and transformed into electrocompetent HF19 cells. Clones were isolated from LB-agar plates and streaked onto new LB-agar plates. Quadruplicate 500 μL LB supplemented with apramycin starter cultures in 2 mL 96-deepwell plates (DWP) were inoculated from each isolated clone. The starter culture was incubated for 6 hr at 37°C 900 rpm in a Heidolph Titramaz 1000/Inkubator 1000. Quadruplicate 500 μL BGM supplemented with apramycin and 100 μM IPTG subcultures in 96-DWP containing the appropriate target compound were inoculated by 50-fold dilutions of the respective starter culture (OD~0.2). The subcultures were incubated for 6 h at 37°C, 900 rpm. The cultures were washed with 1 mL of phosphate-buffered saline prior to measuring the OD and fluorescence.
Deep-well plate dose responses
Isolated clones from the deep-well plate clone screening were digested and cloned back into the parent vector using the same method described above for cloning the libraries into the pFG29 vector containing a degradation tagged GFPuv. The re-cloned mutants were transformed into electrocompetent HF19 cells. Clones were isolated from LB-agar plates supplemented with apramycin and quadruplicate 500 μL LB supplemented with apramycin starter cultures in 2 mL 96-DWP were inoculated from each isolated clone. The starter culture was incubated for 6 h at 37°C, 900 rpm. Quadruplicate 500 μL BGM supplemented with apramycin and 100 μM IPTG subcultures in 96-DWP containing a range of target compound were inoculated by 50-fold dilutions of the respective starter culture. The subcultures were incubated for 16 h at 37°C, 900 rpm. The cultures were washed with 1 mL of phosphatebuffered saline prior to measuring the OD and fluorescence.
Results
Library construction
Our previously reported AraC variant library (called 'SLib4') targeted ligand binding domain residue positions P8, T24, H80, Y82 and H93 for saturation mutagenesis. These positions were selected based on prior structural and amino acid substitution analyses (Tang et al., 2008) . In this study we additionally constructed another 5-site library called 'JLib1s', this time targeting residues T24, R38, H80, Y82, H93. The wild-type AraC ligand binding pocket structure in complex with L-arabinose is depicted in Fig. 1 , with the targeted residue positions highlighted. A key difference between these two libraries involves the lack of amino acid substitutions in the N-terminal arm. Substitutions in this arm generally result in enhanced leaky expression from P BAD Lowe et al., 2014) . While such relaxed repression, potentially resulting from weaker interactions between the N-terminal arm and the DNA-binding domain while in the uninduced (repressing) conformation (Rodgers et al., 2009) , may also promote identification of new variants having altered inducer specificity (though much less sensitive than wild-type) (Tang and Cirino, 2010) , we wondered whether trying to avoid such disruptions in the uninduced state might promote isolation of less leaky (and perhaps more sensitive) variants with altered inducer specificity. Residue P8 was therefore left unchanged in JLib1s, and instead position R38 identified to form a bidentate interaction with O4 and O5 of L-ara in the wild-type crystal structure (Soisson et al., 1997) was targeted for saturated substitutions. Finally, a third AraC library (called 'CLib2s') was created using error-prone PCR to randomly insert substitutions throughout the ligand binding domain (1.6% nucleotide substitution rate in ligand binding domain; 8.8 mutations/gene). Details of plasmid and library construction are provided in the Supplementary Material.
Library screening
The library screening assay was first modified relative to our previous studies, to improve the biosensor signal-to-noise ratio and response stability. Details are provided in the Supplementary Material ('Plasmid and Media Improvements'). The screening protocol described below is outlined in Fig. 2 . JLib1s, CLib2s and SLib4s were separately transformed into screening strain HF19 (total transformants >10
8
) and were individually FACS-sorted based on their repressability in the absence of an inducer (gate included 84, 85 and 75% of the total library populations, respectively). This effectively reduced the fluorescent geometric mean of each population in the absence of any inducer by 15, 5 and 38%, respectively. Plasmid DNA was isolated from the three resulting populations and pooled together. The pooled library (called 'CLib5s') was used as the starting population to screen for gene expression response to individual compounds. The CLib5s library (total transformants 3 × 10 8 ) was first expressed in strain SQ12 (HF19 att HK022 (P BAD -bla)) and challenged by selection on ampicillin plates (100 μg/mL) containing one of the following compounds/concentrations: TAL/5 mM; p-coumaric acid/2 mM and 5 mM; gallic acid/5 mM; gluconic acid lactone/ 5 mM; nicotinic acid/2 mM; phloroglucinol/5 mM; quinic acid/ 5 mM; salicylic acid/2 mM; shikimic acid/5 mM; trans-cinnamic acid/2 mM and 5 mM; and vanillin/2 mM (structures of compounds are shown in Fig. 3 ). The compounds investigated in this study were selected based on their structure, functional groups, and molecular weight (i.e. monocyclic, hydroxy-and/or carboxylic-hydrocarbons) in relation to arabinose and TAL. Compound selection also reflects our interests in developing biosensors specifically for many of these molecules. These concentrations were chosen based on compound solubility, as well as concentrations reflective of those from our previous work to alter AraC effector specificity. Depending on the compound, this selection step reduced the library size by two-to fiveorders of magnitude, with the two orders of magnitude being in the presence of 2 mM vanillin. In the absence of any compound, the background survival rate was 0.0002 ± 0.0001%. The CLib5s population was therefore significantly reduced, decreasing the load on the cytometer for subsequent screening steps. Furthermore, we sought to determine if a single more stringent selection step could result in highly responsive variants. We subjected library CLib5s to 300 μg/mL ampicillin (concentrations >300 μg/mL dramatically reduced survival of the control clone expressing AraC-TAL1 in the presence of 5 mM TAL) as described above with each compound. All surviving colonies were isolated and assayed for response to their respective compound. Of the 18 total colonies screened across all plates, only two clones showed response to their respective compound (both to salicylic acid), as discussed below. Since few clones emerged from this, we next wanted to compare results from the single stringent selection step, to those using less stringency and more screening.
Plasmids were isolated from the populations resistant to 100 μg/mL ampicillin (in the presence of inducer compounds), and introduced next into strain HF19 (chosen instead of SQ12 for this step to avoid added stress from β-lactamase expression). These populations were negative-sorted via FACS in the presence of 100 μM L-ara, which served as a decoy ligand to eliminate non-specific variants (sort gate was set as described in Methods). The negative-sorted populations were then introduced to their respective compounds at the same concentration that was present in the selection plates, and positive-sorted for the most fluorescent cells (top 5%). Some populations were subjected to one additional round of both negative and positive sorting. As depicted in Fig. 2 and described in Table I , positive FACS-screened Fig. 1 Crystal structure of wild-type AraC ligand binding pocket in complex with L-arabinose (2ARC) (Soisson et al., 1997) . Residues targeted for sitesaturation mutagenesis are highlighted and labeled. Fig. 2 Flow diagram for screening. Individual (naïve) libraries were initially subjected to negative-FACS sorting to reduce leaky and non-specific clones. The resulting populations were pooled and subjected to positive selection in the presence of target compounds. The resulting clones were then screened with two rounds of negative-and positive-sorting, followed by a final round of positive selection. Finally, 23 colonies were screened in triplicate in deep-well plates (DWPs) for response to the target inducer compound. The initial pooled libraries were also screened directly to determine if further enrichment was necessary.
populations were additionally subjected to one final round of selection under the more stringent conditions (300 μg/mL ampicillin).
Following the rounds of FACS sorting and selections, 23 clones from each 'endpoint' population were screened for GFP expression in response to their respective compound using a previously described deep-well plate assay (Frei et al., 2016) . The results of these endpoint screens are provided in Table I . Despite the appearance of colonies on selection plates supplemented with p-coumaric 'N' is a negative sort; 'P' is a positive sort; '(Ps)' is a positive selection b N + is the number of clones with >2-fold response; N screened is the total clones screened; '-' indicates no clones >2-fold response. c Clones were isolated directly from selection plates and were not subjected to replicate culturing. acid, t-cinnamic acid, nicotinic acid, quinic acid, gallic acid, shikimic acid and gluconic acid lactone, clones isolated from these endpoint populations were unresponsive in liquid cultures (<2-fold change in fluorescence when induced). Therefore, no clones from these populations were isolated for further analysis.
As anticipated based on our prior work, the endpoint population assays yielded several TAL-responsive clones. Clones responding to vanillin and salicylic acid were similarly isolated. The amino acid substitutions of each clone and the library from which they originated are reported in Table II . Eight different vanillin-responsive AraC variants (AraC-Van1 to AraC-Van8) were identified from the two vanillin endpoint populations (31 out of 46 clones showed greater than or equal to a 2-fold response and were subsequently sequenced). AraC-Van3 was represented three times, with different sets of codons encoding the same residue substitutions. Each of the three clones shows a similar response to vanillin. Six AraC-Van clones originated from library JLib1s, while two (AraC-Van2 and AraC-Van8) were derived from library SLib4s. Each of the isolated variants was subjected to a dose response curve with respect to their target compound up to 10 mM (see Supplementary Fig. S4 ).
Cell culture broths were analyzed by HPLC to monitor stability/ degradation of each target compound. As noted by others (Overhage et al., 2003; Barghini et al., 2007) , vanillin was reduced to vanillyl alcohol after 6 h of culture (confirmed by mass spectrometry; refer to Supplementary Material). All vanillin-responsive variants described below were confirmed to respond to only vanillin, and not to vanillyl alcohol or vanillic acid (results presented in Supplementary Material). We found gallic acid and phloroglucinol to also be degraded after 6 h of cell culture. However since no clones showed significant GFP expression in response to these compounds (or potential degradation products), their degradation was not further investigated.
Specificity of new AraC variants
We previously reported 10 different TAL-responsive AraC variants and verified their specificity toward TAL and structurally similar compounds, although salicylic acid and vanillin were not among the compounds tested (Frei et al., 2016) (an 11th variant was since characterized and is included in the current study). Interestingly, variants 
Clones have the same AA sequence but different codons for the target residues. b Clones were isolated directly from the first round of selection and originate from the error-prone library. (rfu/OD600) 10 mM 5 mM 5 mM 5 mM 7 mM 7 mM 7 mM 7 mM 7 mM Clone 5 mM 5 mM Abbreviations: L-ara, L-arabinose; TAL, triacetic acid lactone; BA, benzoic acid; 2-MBA, 2-methyoxybenzoic acid; 3-HBA, 3-hydroxybenzoic acid; 4-HBA, 4-hydroxybenzoic acid; o-TA, o-toluic acid. AraC-Van8 and AraC-Sal4 show the same amino acid substitution pattern as previously described variants Arac-Tal8 and Arac-Tal1, respectively. We therefore tested the response of these eleven AraC-TAL variants toward salicylic acid and vanillin. We further tested the inducer specificity of all AraC-Van, AraC-Sal and AraC-TAL variants toward various analogs of vanillin and salicylic acid. Escherichia coli clones expressing the individual AraC variants and carrying a P BAD -GFP reporter construct were grown in medium supplemented with a range of concentrations of L-ara, TAL, benzoic acid (BA), 2-methoxybenzoic acid (2MBA), 3-hydroxybenzoic acid (3HBA), 4-hydroxybenzoic acid (4HBA) or o-toluic acid (TA). The response of variants to L-ara, TAL, vanillin, salicylic acid, and the selected analogs are given in Table III .
One of the newly isolated salicylic acid clones (AraC-Sal4) has amino acid substitutions identical to those in a previously isolated TAL variant, 'AraC-TAL1', while AraC-Van8 is identical to our previously reported 'AraC-TAL8' (Tang et al., 2013; Frei et al., 2016) . In that earlier study we identified two distinct patterns of amino acid substitutions in AraC-TAL variants (Pattern 1: T24I or T24L, H80G, Y82I or Y82L, and H93R; Pattern 2: P8G, H80H [codon change CAT to CAC], Y82K and H93[hydrophobic]) (Frei et al., 2016) . Now we see that the first pattern also confers response to salicylic acid (along with TAL), while the second pattern results in response to vanillin (as well as TAL). Note that only two of our eight vanillin variants show this pattern (AraC-Van2 and AraCVan8); the remaining variants are distinctly different, but do share substitution similarities. No vanillin-selected variants respond to salicylic acid, and vice versa, and all TAL variants also respond to either salicylic acid or vanillin, but never both.
With the exception of AraC-Sal1, none of the variants show an induced response >1.7-fold in the presence of any of the other benzoates tested (compounds 'o' through 's' in Supplementary Material). AraC-Sal1 (a product of the random mutagenesis library) on the other hand showed appreciable response to all compounds other than 3-HBA (Table III) . Only variants resulting from the random mutagenesis library (AraC-Sal1 and AraC-Sal2) still respond to the native inducer L-ara. It is also noteworthy that variants AraCSal2, 3, and 4 show no response to the salicylic acid isomers 3-and 4-hydroxybenzoic acid.
Substitution analysis
Schleif and coworkers showed that substitutions at E149 in AraC contribute to elevated leaky expression . This residue is located in the turn of the helix-turn-helix of the ligand binding domain, and is in close proximity to residues H18 and L19 of the N-terminal arm. Interestingly, two of our salicylic acid variants (AraC-Sal1 and AraC-Sal2), both originating from the random mutagenesis library CLib2s, contain a substitution at E149. The variant containing E149G (AraC-Sal1) shows considerably higher leaky expression compared to that containing E149K (refer to Table III ). The E149K substitution may form a hydrogen bond with H18, thereby helping to stabilize the arm in the absence of salicylic acid. Both AraC-Sal1 and AraC-Sal2 were isolated after only a single round of positive selection, and were not isolated again after subsequent screening. Since both variants still show a strong response to L-ara, they were likely removed from the population during negative screening when L-ara was included as a decoy ligand. The amino acid substitutions appearing in these two random mutagenesis variants were inserted one-by-one into wild-type AraC, to quantify their individual effects on response to L-ara, salicylic acid and TAL. As shown in Supplementary Figure, only the substitutions at E149 confer response to salicylic acid, with only E149K conferring any specificity toward salicylic acid.
Discussion
In previous work, FACS served as the sole means of screening large combinatorial libraries (>10 6 ) of AraC variants for response to new inducer compounds. Here, we altered the screening protocol to better accommodate simultaneous screening of multiple libraries (combined library diversity~10 8 variants) by incorporation of a selection early in the screening protocol. By reducing the library size by several orders of magnitude, the burden on FACS screening was significantly reduced, allowing us to screen larger libraries, including a random mutagenesis library, and enabling more rapid screening for responses to a panel of compounds. The result was the isolation of several new AraC variants that respond to the phenolic compounds vanillin and salicylic acid. The inclusion of a random mutagenesis library identified a previously unexplored residue position (E149) as a target for altering AraC ligand response. In addition to furnishing new sensor-regulators of potential value in synthetic biology and high-throughput screening applications, this study provides an expanded amino acid substitution-ligand specificity (sequence-function) data set that can guide future development of customized, AraC-based biosensors.
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